Search

Thomas M. Cunningham

Examiner (ID: 10271)

Most Active Art Unit
1813
Art Unit(s)
1816, 2900, 1813, 2899, 1644, 1806
Total Applications
454
Issued Applications
198
Pending Applications
72
Abandoned Applications
184

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3942235 [patent_doc_number] => 05976845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Composite antibodies of human subgroup IV light chain capable of binding to TAG-72' [patent_app_type] => 1 [patent_app_number] => 8/487743 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 31 [patent_no_of_words] => 19736 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976845.pdf [firstpage_image] =>[orig_patent_app_number] => 487743 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/487743
Composite antibodies of human subgroup IV light chain capable of binding to TAG-72 Jun 6, 1995 Issued
Array ( [id] => 3996212 [patent_doc_number] => 05919910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/477553 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 5435 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919910.pdf [firstpage_image] =>[orig_patent_app_number] => 477553 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/477553
Monoclonal antibodies Jun 6, 1995 Issued
Array ( [id] => 4023900 [patent_doc_number] => 05993827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/487826 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 43938 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/993/05993827.pdf [firstpage_image] =>[orig_patent_app_number] => 487826 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/487826
Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins Jun 6, 1995 Issued
08/467855 METHOD FOR THE TREATMENT OF MALIGNANCIES INVOLVING CELLS EXPRESSING MHC CLASS II ANTIGENS Jun 5, 1995 Abandoned
Array ( [id] => 3937428 [patent_doc_number] => 05976535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore' [patent_app_type] => 1 [patent_app_number] => 8/468513 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38600 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976535.pdf [firstpage_image] =>[orig_patent_app_number] => 468513 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/468513
Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore Jun 5, 1995 Issued
Array ( [id] => 3730414 [patent_doc_number] => 05698201 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Method for treatment of antigenically modified polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/468716 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 48722 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698201.pdf [firstpage_image] =>[orig_patent_app_number] => 468716 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/468716
Method for treatment of antigenically modified polypeptides Jun 5, 1995 Issued
Array ( [id] => 3704323 [patent_doc_number] => 05674982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Multimeric form of human rhinovirus receptor protein' [patent_app_type] => 1 [patent_app_number] => 8/469588 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8851 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674982.pdf [firstpage_image] =>[orig_patent_app_number] => 469588 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/469588
Multimeric form of human rhinovirus receptor protein Jun 4, 1995 Issued
Array ( [id] => 3630796 [patent_doc_number] => 05686582 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Multimeric forms of human rhinovirus receptor protein' [patent_app_type] => 1 [patent_app_number] => 8/464083 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 29 [patent_no_of_words] => 15912 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686582.pdf [firstpage_image] =>[orig_patent_app_number] => 464083 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/464083
Multimeric forms of human rhinovirus receptor protein Jun 4, 1995 Issued
Array ( [id] => 3606835 [patent_doc_number] => 05589343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes' [patent_app_type] => 1 [patent_app_number] => 8/463512 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7384 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589343.pdf [firstpage_image] =>[orig_patent_app_number] => 463512 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/463512
Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes Jun 4, 1995 Issued
Array ( [id] => 3630787 [patent_doc_number] => 05686581 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Multimeric form of human rhinovirus receptor protein' [patent_app_type] => 1 [patent_app_number] => 8/469581 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8862 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686581.pdf [firstpage_image] =>[orig_patent_app_number] => 469581 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/469581
Multimeric form of human rhinovirus receptor protein Jun 4, 1995 Issued
Array ( [id] => 3621992 [patent_doc_number] => 05602031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them' [patent_app_type] => 1 [patent_app_number] => 8/462062 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7457 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602031.pdf [firstpage_image] =>[orig_patent_app_number] => 462062 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/462062
DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them Jun 4, 1995 Issued
Array ( [id] => 3933521 [patent_doc_number] => 05871733 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Multimeric forms of human rhinovirus receptor protein' [patent_app_type] => 1 [patent_app_number] => 8/469587 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 29 [patent_no_of_words] => 15327 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871733.pdf [firstpage_image] =>[orig_patent_app_number] => 469587 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/469587
Multimeric forms of human rhinovirus receptor protein Jun 4, 1995 Issued
Array ( [id] => 3804533 [patent_doc_number] => 05811106 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Plasmodium falciparum thrombospondin-related anonymous proteins (TRAP), fragments and functional derivatives' [patent_app_type] => 1 [patent_app_number] => 8/454619 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5959 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811106.pdf [firstpage_image] =>[orig_patent_app_number] => 454619 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/454619
Plasmodium falciparum thrombospondin-related anonymous proteins (TRAP), fragments and functional derivatives May 30, 1995 Issued
Array ( [id] => 4209673 [patent_doc_number] => 06086865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Methods of treating angiogenesis-induced diseases and pharmaceutical compositions thereof' [patent_app_type] => 1 [patent_app_number] => 8/456280 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3802 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086865.pdf [firstpage_image] =>[orig_patent_app_number] => 456280 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/456280
Methods of treating angiogenesis-induced diseases and pharmaceutical compositions thereof May 30, 1995 Issued
Array ( [id] => 3696064 [patent_doc_number] => 05650487 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Serum immunoregulatory polypeptides and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/455645 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7257 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650487.pdf [firstpage_image] =>[orig_patent_app_number] => 455645 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/455645
Serum immunoregulatory polypeptides and uses therefor May 30, 1995 Issued
Array ( [id] => 3738653 [patent_doc_number] => 05800820 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Methods and compositions for treatment of angiogenic diseases' [patent_app_type] => 1 [patent_app_number] => 8/456132 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8678 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/800/05800820.pdf [firstpage_image] =>[orig_patent_app_number] => 456132 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/456132
Methods and compositions for treatment of angiogenic diseases May 30, 1995 Issued
08/451913 HLA BINDING PEPTIDES AND THEIR USES May 25, 1995 Abandoned
Array ( [id] => 4001498 [patent_doc_number] => 05888519 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Encapsulated high-concentration lipid a compositions as immunogenic agents to produce human antibodies to prevent or treat gram-negative bacterial infections' [patent_app_type] => 1 [patent_app_number] => 8/446174 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6791 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888519.pdf [firstpage_image] =>[orig_patent_app_number] => 446174 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/446174
Encapsulated high-concentration lipid a compositions as immunogenic agents to produce human antibodies to prevent or treat gram-negative bacterial infections May 18, 1995 Issued
Array ( [id] => 3883744 [patent_doc_number] => 05833996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Treatment of psoriasis using dead cells of Mycobacterium vaccae' [patent_app_type] => 1 [patent_app_number] => 8/441980 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1641 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833996.pdf [firstpage_image] =>[orig_patent_app_number] => 441980 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/441980
Treatment of psoriasis using dead cells of Mycobacterium vaccae May 15, 1995 Issued
Array ( [id] => 3662839 [patent_doc_number] => 05599545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Mycobacterium as adjuvant for antigens' [patent_app_type] => 1 [patent_app_number] => 8/441785 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2379 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599545.pdf [firstpage_image] =>[orig_patent_app_number] => 441785 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/441785
Mycobacterium as adjuvant for antigens May 15, 1995 Issued
Menu